Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
May 16, 2022 at 08:15 am EDT
Benitec Biopharma Inc. reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported revenue was USD 0.048 million compared to USD 0.001 million a year ago. Net loss was USD 3.28 million compared to USD 3.91 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.82 a year ago.
For the nine months, revenue was USD 0.073 million compared to USD 0.057 million a year ago. Net loss was USD 13.14 million compared to USD 9.88 million a year ago. Basic loss per share from continuing operations was USD 1.61 compared to USD 2.93 a year ago.